|
BTAF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.87640000000244E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.120400E-03 |
| Normal-vs-Stage2 |
1.98319999999974E-06 |
| Normal-vs-Stage3 |
3.98049999994488E-06 |
| Normal-vs-Stage4 |
5.181600E-04 |
| Stage1-vs-Stage2 |
3.735600E-03 |
| Stage1-vs-Stage3 |
3.688400E-02 |
| Stage1-vs-Stage4 |
1.591410E-01 |
| Stage2-vs-Stage3 |
3.472000E-01 |
| Stage2-vs-Stage4 |
3.796200E-01 |
| Stage3-vs-Stage4 |
9.038400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.205900E-04 |
| Normal-vs-AfricanAmerican |
1.590480E-02 |
| Normal-vs-Asian |
5.511700E-02 |
| Caucasian-vs-AfricanAmerican |
9.376000E-01 |
| Caucasian-vs-Asian |
2.943400E-01 |
| AfricanAmerican-vs-Asian |
4.592400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.595800E-04 |
| Normal-vs-Female |
3.90679999999755E-05 |
| Male-vs-Female |
9.551600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.978700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.52930000000473E-05 |
| Normal-vs-Age(61-80Yrs) |
6.02789999999409E-05 |
| Normal-vs-Age(81-100Yrs) |
5.560800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.872000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.805600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.231390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.317000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.670200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.442400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.808500E-04 |
| Classical-VS-Follicular |
3.320700E-03 |
| Classical-VS-Other |
7.242000E-01 |
| Classical-VS-Normal |
2.260200E-03 |
| Tall-VS-Follicular |
6.028800E-01 |
| Tall-VS-Other |
4.927600E-01 |
| Tall-VS-Normal |
7.73909999973732E-07 |
| Follicular-VS-Other |
5.430400E-01 |
| Follicular-VS-Normal |
2.70250000000694E-06 |
| Other-VS-Normal |
1.382410E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.1658E-05 |
| Normal-vs-N1 |
3.277600E-01 |
| N0-vs-N1 |
3.175900E-02 |
|
|
